A study on echocardiographic findings in hospitalized patients with connective tissue diseases

References

• Chung L, Liu J, Parsons L, Hassoun PM, McGoon M, Badesch DB, et al. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest 2010;138:1383–94.
   PubMed Web of Science ®Google Scholar
• Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): ENDOR. Eur Hear J 2016;37:67–119.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
   PubMed Web of Science ®Google Scholar
• Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677–86.
   PubMed Web of Science ®Google Scholar
• Buck T, Breithardt O-A, Faber L, Fehske W, Flachskampf FA, Franke A, et al. Manual zur Indikation und Durchführung der Echokardiographie. Clin Res Cardiol Suppl. 2009;4:3–51.
   Google Scholar
• Chen J, Tang Y, Zhu M, Xu A. Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis. Clin Rheumatol 2016;35:2437–48.
   PubMed Web of Science ®Google Scholar
• Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996;335:1424–30.
   PubMed Web of Science ®Google Scholar
• Vassiliou VA, Moyssakis I, Boki KA, Moutsopoulos HM. Is the heart affected in primary Sjogren’s syndrome? An echocardiographic study. Clin Exp Rheumatol 2008;26:109–12.
   PubMed Web of Science ®Google Scholar
• Gyöngyösi M, Pokorny G, Jambrik Z, Kovács L, Kovács A, Makula E, et al. Cardiac manifestations in primary Sjögren’s syndrome. Ann Rheum Dis 1996;55:450–4.
   PubMed Web of Science ®Google Scholar
• Coffey S, Cox B, Williams MJA. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J Am Coll Cardiol 2014;63:2852–61.
   PubMed Web of Science ®Google Scholar
• Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809–15.
   PubMed Web of Science ®Google Scholar
• Meier FM, Frommer KW, Dinser R, Walker UA, Czirjak L, Denton CP, et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2012;71:1355–60.
   PubMed Web of Science ®Google Scholar
• Jaeger VK, Wirz EG, Allanore Y, Rossbach P, Riemekasten G, Hachulla E, et al. Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study. PLoS One 2016;11:e0163894.
   PubMed Web of Science ®Google Scholar
• Bhansing KJ, van Riel PL, van Engelen BG, Fransen J, Vonk MC. Patients with systemic sclerosis/polymyositis overlap have a worse survival rate than patients without it. J Rheumatol 2016;43:1838–43.
   PubMed Web of Science ®Google Scholar
• Butt SA, Jeppesen JL, Torp-Pedersen C, Sam F, Gislason GH, Jacobsen S, et al. Cardiovascular manifestations of systemic sclerosis: a Danish nationwide cohort study. J Am Heart Assoc 2019;8:e013405.
   PubMed Web of Science ®Google Scholar
• Nordin A, Svenungsson E, Björnådal L, Elvin K, Larsson A, Jensen-Urstad K. Troponin I and echocardiography in patients with systemic sclerosis and matched population controls. Scand J Rheumatol 2017;46:226–35.
   PubMed Web of Science ®Google Scholar
• Ranque B, Berezne A, Le-Guern V, Pagnoux C, Allanore Y, Launay D, et al. Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features. Scand J Rheumatol 2010;39:498–505.
   PubMed Web of Science ®Google Scholar
• Diederichsen LP, Simonsen JA, Diederichsen AC, Hvidsten S, Hougaard M, Junker P, et al. Cardiac abnormalities in adult patients with polymyositis or dermatomyositis as assessed by noninvasive modalities. Arthritis Care Res 2016;68:1012–20.
   Web of Science ®Google Scholar
• Gonzalez-Lopez L, Gamez-Nava JI, Sanchez L, Rosas E, Suarez-Almazor M, Cardona-Munoz C, et al. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol 1996;14:373–9.
   PubMed Web of Science ®Google Scholar
• Peter A, Balogh A, Szilagyi S, Faludi R, Nagy-Vincze M, Edes I, et al. Echocardiographic abnormalities in new-onset polymyositis/dermatomyositis. J Rheumatol 2015;42:272–81.
   PubMed Web of Science ®Google Scholar
• Plazak W, Kopec G, Tomkiewicz-Pajak L, Rubis P, Dziedzic H, Suchon E, et al. Heart structure and function in patients with generalized autoimmune diseases: echocardiography with tissue Doppler study. Acta Cardiol 2011;66:159–65.
   PubMed Web of Science ®Google Scholar
• Wang H, Liu HX, Wang YL, Yu XQ, Chen XX, Cai L. Left ventricular diastolic dysfunction in patients with dermatomyositis without clinically evident cardiovascular disease. J Rheumatol 2014;41:495–500.
   PubMed Web of Science ®Google Scholar
• Lu Z, Wei Q, Ning Z, Qian-Zi Z, Xiao-Ming S, Guo-Chun W. Left ventricular diastolic dysfunction–early cardiac impairment in patients with polymyositis/dermatomyositis: a tissue Doppler imaging study. J Rheumatol 2013;40:1572–7.
   PubMed Web of Science ®Google Scholar
• Hervier B, Meyer A, Dieval C, Uzunhan Y, Devilliers H, Launay D, et al. Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival. Eur Respir J 2013;42:1271–82.
   PubMed Web of Science ®Google Scholar
• Bodolay E, Csiki Z, Szekanecz Z, Ben T, Kiss E, Zeher M, et al. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 2003;21:313–20.
   PubMed Web of Science ®Google Scholar
• Alpert MA, Goldberg SH, Singsen BH, Durham JB, Sharp GC, Ahmad M, et al. Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation 1983;68:1182–93.
   PubMed Web of Science ®Google Scholar
• Oetgen WJ, Mutter ML, Lawless OJ, Davia JE. Cardiac abnormalities in mixed connective tissue disease. Chest 1983;83:185–8.
   PubMed Web of Science ®Google Scholar
• Leung WH, Wong KL, Lau CP, Wong CK, Cheng CH, Tai YT. Echocardiographic identification of mitral valvular abnormalities in patients with mixed connective tissue disease. J Rheumatol 1990;17:485–8.
   PubMed Web of Science ®Google Scholar
• Leung WH, Wong KL, Lau CP, Wong CK, Cheng CH, Tai YT. Doppler-echo evaluation of left ventricular diastolic filling in patient with mixed connective tissue disease. Cardiology 1990;77:93–100.
   PubMed Web of Science ®Google Scholar
• Vegh J, Hegedus I, Szegedi G, Zeher M, Bodolay E. Diastolic function of the heart in mixed connective tissue disease. Clin Rheumatol 2007;26:176–81.
   PubMed Web of Science ®Google Scholar
• Comens SM, Alpert MA, Sharp GC, Pressly TA, Kelly DL, Hazelwood SE, et al. Frequency of mitral valve prolapse in systemic lupus erythematosus, progressive systemic sclerosis and mixed connective tissue disease. Am J Cardiol 1989;63:369–70.
   PubMed Web of Science ®Google Scholar
• Gunnarsson R, Andreassen AK, Molberg O, Lexberg AS, Time K, Dhainaut AS, et al. Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature. Rheumatol 2013;52:1208–13.
   PubMed Web of Science ®Google Scholar
• Wigley FM, Lima JA, Mayes M, McLain D, Chapin JL, Ward-Able C. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). Arthritis Rheum 2005;52:2125–32.
   PubMed Web of Science ®Google Scholar
• Vegh J, Szodoray P, Kappelmayer J, Csipo I, Udvardy M, Lakos G, et al. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension. Scand J Immunol 2006;64:69–76.
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C, Ahmed S, et al. Cardiac involvement in mixed connective tissue disease: a systematic review. Int J Cardiol 2014;171:326–30.
   PubMed Web of Science ®Google Scholar
• Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 1988;23:380–4.
   PubMed Web of Science ®Google Scholar
• Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med 1975;58:243–64.
   PubMed Web of Science ®Google Scholar
• Deppisch LM, Olusegun Fayemi A. Non-bacterial thrombotic endocarditis. Am Heart J 1976;92:723–9.
   PubMed Web of Science ®Google Scholar
• Nie L-Y, Wang X-D, Zhang T, Xue J. Cardiac complications in systemic sclerosis: early diagnosis and treatment. Chin Med J 2019;132:2865–71.
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas T, Bratis K, Kitas GD, et al. Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases. Int J Cardiol 2017;236:151–6.
   PubMed Web of Science ®Google Scholar
• De Santis M, Crotti C, Selmi C. Liver abnormalities in connective tissue diseases. Best Pr Res Clin Gastroenterol 2013;27:543–51.
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Bounas A, Tektonidou M, Lliossis SNC, et al. Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus. Lupus 2018;27:564–71.
   PubMed Web of Science ®Google Scholar
• Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 2010;69:1269.
   PubMed Web of Science ®Google Scholar
• Bertsias G, Ioannidis JPA, Boletis J, Bombardieri S, Cervera R, Dostal C, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics. Ann Rheum Dis 2008;67:195–205.
   PubMed Web of Science ®Google Scholar